270 related articles for article (PubMed ID: 12163482)
1. Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells.
Ueda T; Mawji NR; Bruchovsky N; Sadar MD
J Biol Chem; 2002 Oct; 277(41):38087-94. PubMed ID: 12163482
[TBL] [Abstract][Full Text] [Related]
2. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform.
Alen P; Claessens F; Schoenmakers E; Swinnen JV; Verhoeven G; Rombauts W; Peeters B
Mol Endocrinol; 1999 Jan; 13(1):117-28. PubMed ID: 9892017
[TBL] [Abstract][Full Text] [Related]
4. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways.
Ueda T; Bruchovsky N; Sadar MD
J Biol Chem; 2002 Mar; 277(9):7076-85. PubMed ID: 11751884
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
Chen T; Wang LH; Farrar WL
Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
[TBL] [Abstract][Full Text] [Related]
6. The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor.
Kasina S; Macoska JA
Mol Cell Endocrinol; 2012 Apr; 351(2):249-63. PubMed ID: 22245379
[TBL] [Abstract][Full Text] [Related]
7. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.
Ikonen T; Palvimo JJ; Jänne OA
J Biol Chem; 1997 Nov; 272(47):29821-8. PubMed ID: 9368054
[TBL] [Abstract][Full Text] [Related]
8. The co-regulators SRC-1 and SMRT are involved in interleukin-6-induced androgen receptor activation.
Wang Q; Wang H; Ju Q; Ding Z; Ge X; Shi QM; Zhou JL; Zhou XL; Zhang JP; Zhang MR; Yu HM; Xu LC
Eur Cytokine Netw; 2016 Nov; 27(4):108-113. PubMed ID: 28396297
[TBL] [Abstract][Full Text] [Related]
9. The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3.
Chipuk JE; Cornelius SC; Pultz NJ; Jorgensen JS; Bonham MJ; Kim SJ; Danielpour D
J Biol Chem; 2002 Jan; 277(2):1240-8. PubMed ID: 11707452
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
Culig Z; Bartsch G; Hobisch A
Mol Cell Endocrinol; 2002 Nov; 197(1-2):231-8. PubMed ID: 12431817
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of androgen receptor coactivators in prostate cancer.
Culig Z; Comuzzi B; Steiner H; Bartsch G; Hobisch A
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):265-71. PubMed ID: 15663989
[TBL] [Abstract][Full Text] [Related]
12. Effect of type I growth factor receptor tyrosine kinase inhibitors on phosphorylation and transactivation activity of the androgen receptor in prostate cancer cells: Ligand-independent activation of the N-terminal domain of the androgen receptor.
Sugita S; Kawashima H; Tanaka T; Kurisu T; Sugimura K; Nakatani T
Oncol Rep; 2004 Jun; 11(6):1273-9. PubMed ID: 15138566
[TBL] [Abstract][Full Text] [Related]
13. p300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6.
Debes JD; Schmidt LJ; Huang H; Tindall DJ
Cancer Res; 2002 Oct; 62(20):5632-6. PubMed ID: 12384515
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM
Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464
[TBL] [Abstract][Full Text] [Related]
15. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
Xie Y; Wolff DW; Lin MF; Tu Y
Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
[TBL] [Abstract][Full Text] [Related]
17. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity.
Fu M; Rao M; Wu K; Wang C; Zhang X; Hessien M; Yeung YG; Gioeli D; Weber MJ; Pestell RG
J Biol Chem; 2004 Jul; 279(28):29436-49. PubMed ID: 15123687
[TBL] [Abstract][Full Text] [Related]
18. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
Dutertre M; Smith CL
Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
Powell SM; Christiaens V; Voulgaraki D; Waxman J; Claessens F; Bevan CL
Endocr Relat Cancer; 2004 Mar; 11(1):117-30. PubMed ID: 15027889
[TBL] [Abstract][Full Text] [Related]
20. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]